CBK-323

N/A

Report date: 2024/08/28 16:26:45
NME

Base Information

Drug NameCBK-323
Drug Alias NameCBK323CBK-323
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesThe Calibr-Skaggs Institute for Innovative Medicines
China Registration ClassN/A

Develop Information

Active CompaniesThe Calibr-Skaggs Institute for Innovative MedicinesShanghai Ark Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A